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Background
Proteomic biomarkers are sets of proteins that may be
detected in biofluids for disease detection, prognosis,
and treatment selection. Vanderbilt University is taking
part in two National Cancer Institute initiatives to estab-
lish a basis for clinical biomarkers. The first, Clinical
Proteomic Technology Assessment for Cancer
(CPTAC), characterizes proteomic technologies for dis-
covery and validation of biomarkers. The second, the
Early Detection Research Network (EDRN), attempts to
develop new sets of biomarkers and evaluate their effec-
tiveness in clinically relevant samples. The quest for bio-
markers is fraught with challenges for both “bench”
experiments and bioinformatics. Here, we examine
sources of discrepancy at several levels. The search
engines that identify peptides from LC-MS/MS experi-
ments differ significantly in the set of spectra that they
identify from experiments. Parsimonious protein assem-
bly may prune out proteins in one experiment and
retain them in another. Protein differentiation tools may
yield divergent results, even when starting from the
same data sets. Verifying biomarkers through targeted
proteomics has only recently been supported by tools
that can work across instruments from different ven-
dors. Translating cancer biology knowledge into clini-
cally relevant tests for this disease will require care at all
these levels.
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